|
|
Volumn 26, Issue 5, 2011, Pages 636-637
|
|
Vitamin e for nonalcoholic fatty liver disease
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ALKALINE PHOSPHATASE;
ALPHA TOCOPHEROL;
ASCORBIC ACID;
ASPARTATE AMINOTRANSFERASE;
CYTOKINE;
ICOSANOID;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
INSULIN;
PIOGLITAZONE;
PLACEBO;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ALKALINE PHOSPHATASE BLOOD LEVEL;
ALTERNATIVE MEDICINE;
ANTIINFLAMMATORY ACTIVITY;
APOPTOSIS;
ARTICLE;
ASPARTATE AMINOTRANSFERASE BLOOD LEVEL;
BLEEDING TIME;
CAUSE OF DEATH;
CELL DAMAGE;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
EXERCISE;
HUMAN;
INCIDENCE;
INSULIN RESISTANCE;
LIVER CELL;
LIVER FIBROSIS;
LOW FAT DIET;
MAJOR CLINICAL STUDY;
NECROSIS;
NONALCOHOLIC FATTY LIVER;
OBESITY;
OXIDATIVE STRESS;
PATIENT COUNSELING;
RANDOMIZED CONTROLLED TRIAL;
RISK ASSESSMENT;
RISK FACTOR;
SCIENTIFIC LITERATURE;
STEATOSIS;
TREATMENT DURATION;
VITAMIN SUPPLEMENTATION;
WEIGHT REDUCTION;
ANIMALS;
FATTY LIVER;
HUMANS;
OBESITY;
VITAMIN E;
VITAMINS;
|
|
EID: 80053244337
PISSN: 08845336
EISSN: 19412452
Source Type: Journal
DOI: 10.1177/0884533611418343 Document Type: Article |
|
Times cited : (1)
|
|
References (8)
|
